Pathological Complete Response and Prognosis in Patients Receiving Neoadjuvant Paclifaxel and Trastuzumab with and without Anthracyclines for Stage II and III, HER2-positive Operable Breast Cancer : A Single-institute Experience
Pathological Complete Response and Prognosis in Patients Receiving Neoadjuvant Paclifaxel and Trastuzumab with and without Anthracyclines for Stage II and III, HER2-positive Operable Breast Cancer : A Single-institute Experience
复制标题
接受新辅助紫杉醇和曲妥珠单抗联合或不联合蒽环类药物治疗 II 期和 III 期 HER2 阳性可手术乳腺癌患者的病理完全缓解和预后：单机构经验
作者：
Nishimura N;Nakano K;Ueda K;Kodaira M;Yamada S;Mishima Y;Yokoyama M;Terui Y;Takahashi S;Hatake K;Ishikawa Y;Horiguchi J
